title: The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010.
abstract: Well-recognized experts in the field of gastric cancer discussed during the 12th European Society Medical Oncology (ESMO)/World Congress Gastrointestinal Cancer (WCGIC) in Barcelona many important and controversial topics on the diagnosis and management of patients with gastric cancer. This article summarizes the recommendations and expert opinion on gastric cancer. It discusses and reflects on the regional differences in the incidence and care of gastric cancer, the definition of gastro-esophageal junction and its implication for treatment strategies and presents the latest recommendations in the staging and treatment of primary and metastatic gastric cancer. Recognition is given to the need for larger and well-designed clinical trials to answer many open questions.
authors.affiliation: University Hospital Gasthuisberg, Leuven, Belgium. Eric.VanCutsem@uzleuven.be
authors.forename: E
authors.initials: E
authors.lastname: Van Cutsem
authors.forename: M
authors.initials: M
authors.lastname: Dicato
authors.forename: R
authors.initials: R
authors.lastname: Geva
authors.forename: N
authors.initials: N
authors.lastname: Arber
authors.forename: Y
authors.initials: Y
authors.lastname: Bang
authors.forename: A
authors.initials: A
authors.lastname: Benson
authors.forename: A
authors.initials: A
authors.lastname: Cervantes
authors.forename: E
authors.initials: E
authors.lastname: Diaz-Rubio
authors.forename: M
authors.initials: M
authors.lastname: Ducreux
authors.forename: R
authors.initials: R
authors.lastname: Glynne-Jones
authors.forename: A
authors.initials: A
authors.lastname: Grothey
authors.forename: D
authors.initials: D
authors.lastname: Haller
authors.forename: K
authors.initials: K
authors.lastname: Haustermans
authors.forename: D
authors.initials: D
authors.lastname: Kerr
authors.forename: B
authors.initials: B
authors.lastname: Nordlinger
authors.forename: J
authors.initials: J
authors.lastname: Marshall
authors.forename: B D
authors.initials: BD
authors.lastname: Minsky
authors.forename: Y K
authors.initials: YK
authors.lastname: Kang
authors.forename: R
authors.initials: R
authors.lastname: Labianca
authors.forename: F
authors.initials: F
authors.lastname: Lordick
authors.forename: A
authors.initials: A
authors.lastname: Ohtsu
authors.forename: N
authors.initials: N
authors.lastname: Pavlidis
authors.forename: A
authors.initials: A
authors.lastname: Roth
authors.forename: P
authors.initials: P
authors.lastname: Rougier
authors.forename: H J
authors.initials: HJ
authors.lastname: Schmoll
authors.forename: A
authors.initials: A
authors.lastname: Sobrero
authors.forename: J
authors.initials: J
authors.lastname: Tabernero
authors.forename: C
authors.initials: C
authors.lastname: Van de Velde
authors.forename: J
authors.initials: J
authors.lastname: Zalcberg
mesh_terms: D020022:Genetic Predisposition to Disease; D006801:Humans; D009362:Neoplasm Metastasis; D017410:Practice Guidelines as Topic; D011379:Prognosis; D012307:Risk Factors; D013274:Stomach Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D015996:Survival Rate